WEDNESDAY, April 9, 2025 (HealthDay News) — An experimental drug can help patients with advanced multiple sclerosis (MS) delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib, delayed disability progression by 31% in people with a type of MS called non-relapsing secondaryContinue Reading

WEDNESDAY, April 9, 2025 (HealthDay News) — Folks with low back pain can use their minds to effectively cope with their suffering, a new clinical trial says. Mindfulness meditation and cognitive-behavioral therapy (CBT) both significantly reduced pain among people with chronic back pain, according to findings published Monday in JAMAContinue Reading